Investor Relations

INVESTOR RELATIONS

Overview

Zogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
(Common Stock)
Data as of  08/17/18 3:31 PM EDT
Copyright Nasdaq. Minimum 15 minutes delayed